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Medicine
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Abstract
A determination of the glomerular filtration rate (GFR) with high accuracy is of
great relevance especially in cases of insufficient kidney function. In nuclear medicine,
the standard method is based on blood sample measurements with Cr-51 ethylenedia-
minetetraacetic acid (Cr-51-EDTA) or Tc-99m diethylene-triamine-pentaacetate
(Tc-99m-DTPA), providing very high accuracy and reliability. In particular, the
slope-intercept method turned out to be the most appropriate and is therefore rou-
tinely used in many hospitals worldwide. For this purpose, blood samples are drawn at
certain time points starting 120 minutes after injection, which are then measured
together with a standard probe in a gamma counter; based on the results, the GFR
calculation is then usually performed automatically with an appropriate software. In
this chapter, the mathematical background as well as a step-by-step description of the
slope-intercept method is given. In our study, we found that at least three blood
samples should be drawn in order to achieve highest quality and reliability. Further-
more, a sample size of at least three blood samples allows an error calculation which
provides an estimation of the reliability of the preceding measurement.
Keywords: glomerular filtration rate, slope-intercept method, error calculation,
nuclear medicine, Cr-EDTA, Tc-DTPA
1. Introduction
The glomerular filtration rate (GFR) is an important clinical measure for estimat-
ing not only the health of the kidneys but also the overall health of a patient, since it is
directly proportional to the number of working nephrons. However, an exact deter-
mination of the GFR is not simple, and very often, an estimated GFR (eGFR) is
calculated from the serum creatinine in the blood [1, 2]. For this, various formulas are
available for different purposes [2–4]. Although these methods are convenient, they
are not very sensitive, in particular in the case of insufficient kidney function [5].
An approved method for an accurate determination of the GFR was the inulin
clearance, because inulin serves as a marker which is filtered by the glomeruli
without tubular secretion or reabsorption [6]. Considered as gold standard, this
method is time-consuming and needs urine as well as blood sample collection.
In nuclear medicine, several invasive and noninvasive methods are available to
calculate the GFR. In principle, radiotracers, i.e., biological markers labeled with a
radioactive isotope, are injected into the patient. The behavior of the tracer gives
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information about the health condition of the organ and can be tracked by the
emitted radiation from the labeled isotope. After injection, the radiation and there-
fore the concentration of the tracer can be measured either from drawn blood
samples or with imaging techniques (so-called renal scintigraphy). The latter thus
additionally allow a visualization of the anatomical properties of the organ.
To give an example, the very common radio tracer MAG3 (mercaptoacetyl-
triglycine, labeled to the gamma emitting isotope Tc-99m), providing excellent
image quality, is not filtered in the glomeruli and therefore used with imaging
techniques to determine the split renal function and the renal transit [7]. In con-
trary, the tracers Tc-99m diethylene-triamine-pentaacetate (Tc-99m-DTPA) and
Cr-51 ethylenediaminetetraacetic acid (Cr-51-EDTA) are similar to inulin and
therefore used to determine the GFR [8].
Cr-51-EDTA is only suitable for blood sample measurements since the physical
properties of its labeled isotope Cr-51 do not allow the usage of imaging techniques.
Tc-99m-DTPA on the other hand might be used for both blood sample and imaging
methods.
For the sake of completeness, it is mentioned that methods are available to
estimate the GFR from renal scintigraphy images, based on the accumulation of Tc-
99m-DTPA in the kidneys within the first minutes after injection [9]. However,
these methods only provide an estimation of the GFR and will therefore not be
discussed in this chapter.
The main purpose of this chapter is to introduce the idea and the measurement
procedure of the so-called slope-intercept method. In short, an appropriate tracer
such as Tc-99m-DTPA or Cr-51-EDTA is injected, and at least two blood samples
are taken at certain time points after the injections. The blood samples are then
measured in a detector, a so-called gamma counter, in order to determine the
emitted radiation, from which the GFR can be calculated. Methods using only one
or two blood samples exist, but these are less accurate and error-prone [10]. The
most accurate method involves the measurement of at least three blood samples
because in this case a determination of the systematic error can be provided which
in turn gives information about the reliability of the measurement.
2. Mathematical background
2.1 GFR calculation
For the determination of the GFR from an appropriate tracer, e.g., Tc-99m-DTPA
or Cr-51-EDTA, the area under the so-called plasma concentration curve is needed,
which is obtained from the drawn blood samples as described in the following.
After injection, the tracer travels through the blood vessels into the kidneys,
where it is freely filtered and finally excreted. Assuming that other renal processes
of the tracer are negligible, the decrease of the tracer concentration in the blood
plasma after certain time points is then a measure for the glomerular filtration.
Ideally, starting at 1 hour after injection, every 30 or 60 minutes a blood sample is
drawn, in particular in the case of three blood samples at 120, 180, and 240 minutes
after injection (see Figure 1) [11]. Due to its radioactivity, i.e., its emission of
radiation, the tracer concentration in the blood plasma samples can be measured,
usually with a gamma counter which allows the measurement of small samples.
The decrease of the tracer concentration in the blood plasma, expressed with a
function P(t), follows an exponential decay. This means due to glomerular filtra-
tion, the initial tracer concentration in the body (P0) is decreasing exponentially
(time, t) with a certain biological decrease constant L.
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P tð Þ ¼ P0  e
Lt (1)
The area A under this curve obviously is
A ¼
P0
L
(2)
The curve P(t) is obtained by fitting the measured blood plasma samples with
the exponential function from Eq. (1) (see Figure 1), e.g., with a least squares
algorithm. The fit parameters are the values P0 (the “intercept”) and L (the
“slope”), which are then used to calculate A.
Another information needed for the GFR calculation is the applied dose to the
patient. While the syringe with the tracer is measured in an activimeter (or a
comparable detector) before injection, the blood samples, showing considerably less
radioactivity, are measured in a very different device (gamma counter). In order to
connect the measurements of both devices, a so-called standard (a small amount of
the tracer) must be prepared, which is then measured in both devices. The ratio of
these two measurements is used to convert the injected dose measured in the
activimeter to the units of the gamma counter. The converted applied dose D
therefore can be written as
D ¼ ActSyringe 
ActStd
GCStd
(3)
with ActSyringe as measured syringe activity before application and ActStd as
standard activity in the activimeter and GCStd as measured standard activity in the
gamma counter.
The GFR can then be expressed as the converted total dose applied to the
patient, D, divided by the area under the plasma concentration curve [11]
GFR ¼
D  V
A
(4)
with V as the dilution of the standard (usually around 500, see Section 3).
Therefore, using Eqs. (2) and (3), the GFR can be written as
GFR ¼ ActSyringe 
ActStd
GCStd
 V 
L
P0
(5)
Figure 1.
Measured tracer concentrations of three plasma samples are plotted as dots; an exponential curve (see Eq. (1))
was fitted through the data points (line). The abscissa gives the time in minutes after injection of the tracer.
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2.2 Corrections
2.2.1 AUC correction
Due to underlying biological processes, the plasma concentration curve P(t)
appears not as a perfect exponential decay in particular in the beginning, leading to
a wrong area under the curve (AUC). This can be solved by fitting the curve with
multiple exponential curves, which would need much more blood samples. Another
option is to start blood sample withdrawal after 120 minutes, i.e., after initial renal
processes, using a simple AUC correction formula. Several formulas for adults and
children are provided [11–14]. The Brochner-Mortensen correction is
recommended [11, 15]:
For adults
GFRcorr ¼ 0:9908  GFR 0:001218  GFR
2
For children
GFRcorr ¼ 1:01  GFR 0:0017  GFR
2
2.2.2 Radioactive decay correction
Furthermore, both tracers not only have a biological half-life due to their glo-
merular clearance but also a physical half-life due to the radioactivity of their
labeled isotopes. Consequently, the tracer concentration in the blood samples not
only decreases due to the biological clearance but virtually also due to the physical
loss of decayed isotopes which are labeled to the tracer.
Keeping in mind that the blood samples for the GFR determination with the
slope-intercept method must be drawn 3 or even more hours after injection and the
half-life of the isotope is not infinite, the physical half-life of the isotope might lead
to a significant loss of tracer concentration due to its radioactivity (and not due to
glomerular filtration). Ideally, the physical half-life of the corresponding isotope
therefore should be very high in order to minimize the concentration loss due to
radioactivity. This issue is illustrated in Figure 2.
In case of Cr-51-EDTA, the physical half-life of Cr-51 is 27.7 days. Assuming
that, starting with injection, the blood sample withdrawing takes 4 hours, one can
easily calculate that the virtual loss of tracer concentration due to its radioactivity
during this time interval is about 1%. The radioactivity of Cr-51 therefore can be
considered as negligible and the tracer can be treated as physically stable (see
Figure 2).
On the other hand, the isotope Tc-99m from the tracer Tc-99m-DTPA has a
physical half-life of about 6 hours; the concentration loss during a time period of
4 hours is not negligible anymore. As illustrated in Figure 2, measured values of
drawn sample appear with a significantly lower measured concentration value due
to the radioactive decay of Tc-99m; in this example, the calculated GFR would be
falsely overstated by 20%. Thus, measurements with Tc-99m-DTPA must be
corrected for the physical half-life of Tc-99m.
2.2.3 Background correction
Another important issue is the unavoidable measurement of unintended radio-
activity. First, the remaining radioactivity in the syringe after injection must be
measured and subtracted from the applied dose. Furthermore, both activimeter and
4
Glomerulonephritis and Nephrotic Syndrome
gamma counter continuously measure background radiation which must be
subtracted from all measured values.
2.2.4 BSA correction
Since the GFR varies with the body surface area (BSA), it usually is presented as
pure value but also corrected for the body surface area (BSA-GFR), normalized to
the “standard man” (body surface 1.73 m2). Several formalisms are available to
estimate the body surface area for adults and children [16–20].
2.3 Error calculation
In clinical routine, irregularities during the measurement process, inadvertence,
radioactive contamination, and other so-called systematic errors might lead to
inaccurate results. Statistical (random) errors from the activimeter and gamma
counter measurements are assumed to be negligible [10].
To estimate these systematic errors, the error of the area under the tracer
concentration curve A (Eq. (2)) can be calculated after the fitting procedure [10],
provided at least three blood samples have been taken. According to the Gaussian
error propagation law, the errors of L and P0 need to be calculated in order to obtain
the error of A:
sA ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
sP0
L
 2
þ
sL  P0
L2
 2s
(6)
with sA as error of the area under the curve A, sP0 as error of P0, and sL as error of
L. This problem can be solved analytically, leading to
sL ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
n 
1
n 2

P
lnP0  Lti  lnP tið Þð Þ
2
n
P
t2i 
P
tið Þ
2
s
(7)
sP0 ¼ P0 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiX
ti2 
1
n 2

P
lnP0  Lti  lnP tið Þð Þ
2
n
P
t2i 
P
tið Þ
2
s
(8)
with ti as time interval after injection.
Figure 2.
Exponential decrease due to glomerular filtration with a typical half-life of 90 minutes (gray dots). Due to
radioactive decay, real obtained curves are shown as black line in the case of Cr-51 and as gray line in the case
of Tc-99m.
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Under the assumption that random errors are negligible, sA represents the error
of the calculated GFR. Although errors of <10% are considered insignificant, high
errors allow to identify irregularities and re-evaluate the results.
3. Measurement
3.1 Preparation
A standard is prepared, i.e., 1 ml of the used tracer is filled in an appropriate
holder. Both the standard and the full syringe are measured in the activimeter. The
empty syringe must also be measured after application in order to subtract the
remaining activity from the measured value before application. In Eq. (3), this
delivers the values ActSyringe and ActStd.
3.2 Blood sample measurement
At least three blood samples are taken, starting at 120 minutes after injection,
with an interval of 1 hour. The exact time period between injection and blood
sample withdrawal needs to be recorded in order to minimize errors.
The standard usually needs to be diluted, e.g., by a factor of around 500. Around
1 ml is transferred into holders appropriate for the gamma counter. After separating
blood plasma from hematocrit, 1 ml of each plasma sample is also transferred into
holders for the gamma counter; all probes are measured. This gives the value GCStd
as well as all necessary data points to obtain the plasma concentration curve P(t)
(Eq. (1)).
3.3 GFR calculation procedure
Before starting any calculations, all measured values need to be corrected for
background. Note that in case of Tc-99m-DTPA, values need to be corrected for
radioactive decay. The measured data points are fitted with an exponential function
(Eq. (1)) to obtain the plasma concentration curve function P(t) and from this P0
and L, which are needed to calculate the GFR (Eq. (5)).
If possible, i.e., if more than two blood samples have been drawn, the error is
calculated according to Eq. (6). Furthermore, AUC correction and BSA correction
are applied to the final GFR result.
4. Comparison of different blood sample methods
There are several methods allowing an estimation of the GFR from only one
blood sample [21–24]. Although these methods are from high convenience for the
routine and the patients, they are not recommended for low GFRs [11] and show
significant deviations to the slope-intercept method [10].
The slope-intercept method with blood samples drawn after 120 minutes after
injection is suggested to be the best compromise between accuracy and simplicity; it
furthermore is a repeatable and reliable method [10, 11, 25, 26]. Since an error
calculation helps in identifying errors in the measurement process such as radioac-
tive contamination or irregularities in the routine, the slope-intercept method with
three blood samples appears ideal.
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5. Conclusions
The slope-intercept method is based on several blood samples and an accurate
calculation procedure including corrections and error estimation. In particular in
case of low GFRs, this method is the best compromise between the effort for the
clinical routine, patients comfort, and accuracy.
Appendices and nomenclature
Abbreviations
AUC area under the curve
BSA body surface area
GFR glomerular filtration rate
Nomenclature
Tc-99m-DTPA Tc-99m diethylene-triamine-pentaacetate
Cr-51-EDTA Cr-51ethylenediaminetetraacetic acid
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